Dose selection for a direct and selective factor IXa inhibitor and its complementary reversal agent: translating pharmacokinetic and pharmacodynamic properties of the REG1 system to clinical trial design - Povsic, TJ; Cohen, MG; Chan, MY (J Thromb Thrombolysis, 2011)
et al.